Is a
Other attributes
Member of Board of Directors of
Dr. Ansbert Gadicke is co-founder and Managing Director of MPM and its venture capital activities, Managing Partner of the Oncology Impact Funds, private/public funds focused on oncology as well as new modalities managed by MPM. He is the driving force at MPM behind building leading biopharmaceutical companies such as BioMarin Pharmaceuticals, Idenix Pharmaceuticals (acquired by Merck & Co.), Mitobridge (acquired by Astellas), and Pharmasset (acquired by Gilead Sciences) and, more recently, Cullinan Oncology (NASDAQ: CGEM), iTeos Therapeutics (NASDAQ: ITOS) and AlloVir (NASDAQ: ALVR).
Timeline
No Timeline data yet.
Current Employer
Patents
Further Resources
No Further Resources data yet.
